Sudarshan Chemical Industries Limited has announced a scheduled analyst and institutional investor interaction with DSP Mutual Fund, demonstrating the company's commitment to maintaining transparent communication with stakeholders and compliance with regulatory requirements.

Meeting Details and Schedule

The interaction has been organized as a structured engagement between the company and institutional investors. The meeting specifics have been clearly outlined to ensure proper coordination and regulatory compliance.

Regulatory Compliance Framework

The announcement has been made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time. This regulation mandates listed companies to inform stock exchanges about material events and information that could impact investor decisions.

The company has proactively disclosed this interaction to both major stock exchanges - BSE Limited and National Stock Exchange of India Limited - ensuring full transparency in its investor engagement activities.

Important Disclaimers and Conditions

Sudarshan Chemical Industries has provided several important clarifications regarding the scheduled meeting:

• The meeting details remain subject to change due to potential exigencies
• Logistical disorders may necessitate schedule modifications
• Last-minute conflicts from analysts, institutional investors, or company representatives could impact timing
• No unpublished price sensitive information will be discussed during the interaction

The company has emphasized that it does not intend to share any material non-public information during these meetings, maintaining strict adherence to insider trading regulations and fair disclosure practices.

Corporate Governance and Transparency

This scheduled interaction reflects the company's ongoing commitment to maintaining regular dialogue with institutional investors and analysts. Such meetings are essential components of corporate governance frameworks, enabling institutional stakeholders to better understand company operations, strategies, and performance metrics.

The formal notification was signed by Mandar Velankar, General Counsel and Company Secretary, on March 16, 2026, ensuring proper authorization and documentation of the announcement.

Sudarshan Chemical Industries Limited has approved its unaudited financial results for Q3FY26, demonstrating mixed performance across standalone and consolidated operations. The Board of Directors approved these results at their meeting held on February 12, 2026, for the quarter and nine months ended December 31, 2025.

Standalone Financial Performance

The company's standalone operations showed resilience with improved profitability despite revenue decline. Key performance metrics for Q3FY26 are presented below:

For the nine months ended December 31, 2025, standalone revenue reached ₹1,664.0 crore compared to ₹1,830.4 crore in the previous year, while net profit increased significantly to ₹169.9 crore from ₹118.6 crore.

Consolidated Financial Results

The consolidated performance reflects the substantial impact of the Heubach acquisition completed in March 2025. The consolidated financial metrics demonstrate:

The consolidated nine-month revenue reached ₹6,987.3 crore compared to ₹1,996.1 crore in the previous year, primarily driven by the Heubach acquisition integration.

Exceptional Items and Labour Code Impact

The company reported exceptional items expense of ₹26.5 crore in standalone results and ₹45.4 crore in consolidated results for Q3FY26. This primarily relates to the statutory impact of new Labour Codes notified by the Government of India on November 21, 2025, affecting gratuity calculations due to changes in wage definition. The incremental impact consists of gratuity of ₹43.2 crore and long-term compensated absences of ₹3.1 crore in consolidated results.

Segment Performance Analysis

The pigments segment, forming the core business operations, generated substantial revenue growth:

Corporate Developments and Approvals

Several significant corporate actions were completed during the period:

The Board approved renewal of corporate guarantee to The Hongkong and Shanghai Banking Corporation Limited for EURO 6 million on behalf of Sudarshan Europe B.V., the company's wholly owned subsidiary, for securing revolving credit facility. The company also made multiple allotments of employee stock options under the Sudarshan Employee Stock Option Plan, 2018, with total allotments of 39,051 options during the financial year.